secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-08-12T23:59:59+00:00
Accession:  0001193125-25-179012
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics shareholders approve reverse stock split authorization and up to $50M issuance to Lincoln Park
--------------------------------------------------------------------------------

- All six director nominees were elected to the board for a term expiring at the 2026 annual meeting.
- Approved potential issuance of up to $50M common stock plus $1M commitment fee to Lincoln Park Capital Fund.
- Board authorized to effect a reverse stock split at a ratio between 1:2 and 1:250 within 12 months.
- Advisory vote on executive compensation passed with 16,714,842 votes for and 858,028 against.
- Fifth amendment and restatement of the 2020 Stock Incentive Plan was approved by stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525179012/0001193125-25-179012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525179012/d71976d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-179012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer